Ectropion of cervix uteri. Erosion and ectropion of cervix uteri
Conditions
Interventions
Intervention 1: Control group: the use of a single dose of 500 mg vaginal tablet of tranexamic acid by a clinical caregiver using an applicator and maintaining the lithotomy position for 15 minutes in
Sponsors
Vice-Chancellor for Research and Technology of Zanjan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 45 years Complaining of symptoms caused by cervical ectropion, including mucopurulent secretions, postcoital bleeding, and pelvic pain
Exclusion criteria
Exclusion criteria: Menopause Being pregnant or becoming pregnant Taking contraceptives The presence of an IUD in the uterus Known malignancy Unwillingness to participate in the study Abnormal pap smear result Pelvic inflammatory disease HIV infection Any internal or external genital cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of participants with spoting. Timepoint: Before the start of the intervention, immediately after the start of the intervention, and then the first week. Method of measurement: Medical History.;The percentage of participants with dyspareunia. Timepoint: Before the start of the intervention, immediately after the start of the intervention, and then the first week. Method of measurement: Medical History.;The percentage of participants with postcoital bleeding. Timepoint: Before the start of the intervention, immediately after the start of the intervention, and then the first week. Method of measurement: Medical History.;The percentage of participants with vaginal discharge. Timepoint: Before the start of the intervention, immediately after the start of the intervention, and then the first week. Method of measurement: physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRazie Rezaei
Zanjan University of Medical Sciences
Outcome results
None listed